Morgan Stanley raised the firm's price target on Cinemark to $30 from $28 and keeps an Equal Weight rating on the shares. Cinemark is "well positioned to benefit" from a box office recovery this year and next, but the firm cites risk to industry box office consensus and current valuation levels for its Equal Weight rating.
